ÂÜÀòÂÒÂ×

Log inSign up

Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou
President & CEO

William Chou

Collapse
JW
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
SA
Samiah Al-Zaidy
VP, Clinical Development
EF
Eden Fucci
VP, Manufacturing Operations
TV
Tiffini Voss
VP, Clinical Development
SH
Stuart Henderson
VP, Corporate Development & Investor Relations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
AP
Anne Marie Pierce
Finance Operations Specialist
Patricia Elsasser
Director Clinical Operations
Derek Kichula
Senior Director, Engineering & General Manager
Rich Mastropietro
Executive Director, IT
Karl Whitney
Senior Vice President, Global Regulatory Affairs
Samiah A. A.
Vice President Clinical Development
Pamela H.
Vice President Clinical Operations
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy
GI
Glen Kerker II
Director, Regulatory Operations

Teams

+9

Leadership Team

12 members

+9

Scientific Research and Development

12 members

GI
+6

Clinical Operations and Quality Assurance

9 members

+2

Finance and Administrative Support

5 members

Similar companies

SpringWorks Therapeutics

5 followers

REVOLUTION Medicines

5 followers

Kymera Therapeutics

5 followers

Halozyme Therapeutics

4 followers

Summit Therapeutics

4 followers

Stemline Therapeutics

3 followers

CytomX

3 followers

Celularity

3 followers

Atomwise

3 followers

Celldex Therapeutics

2 followers

Fortis Life Sciences

1 follower

Explore companies